Schuetz Thomas J.
Insider CIK 1591464 · RLYP Director · BOLD Director · NONE President of R&D, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2026-02-08 | 2026-02-10 | 36,687 | $6.52 | $239.2K | 6,603,336 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2026-01-09 | 2026-01-12 | 46,777 | $5.35 | $250.3K | 6,640,023 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 250,000 | $5.17 | $1.29M | 6,686,800 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2025-11-16 | 2025-11-18 | 44,025 | $4.83 | $212.6K | 6,436,800 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2025-05-27 | 2025-05-27 | 10,000 | $2.11 | $21.1K | 6,480,825 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2025-02-08 | 2025-02-11 | 41,687 | $3.50 | $145.9K | 6,470,825 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2025-01-09 | 2025-01-13 | 58,054 | $1.86 | $108.0K | 6,512,512 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2024-02-08 | 2024-02-09 | 44,782 | $1.45 | $64.9K | 6,570,566 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2024-01-09 | 2024-01-10 | 637,500 | — | $0 | 637,500 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2024-01-09 | 2024-01-10 | 637,500 | $1.93 | $1.23M | 6,615,348 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2023-11-17 | 2023-11-21 | 44,025 | $1.50 | $66.0K | 5,977,848 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2023-03-10 | 2023-03-10 | 10,000 | $3.37 | $33.7K | 6,021,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2023-02-27 | 2023-02-27 | 20,000 | $3.98 | $79.6K | 6,011,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2023-02-15 | 2023-02-15 | 20,000 | $3.86 | $77.2K | 5,991,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2023-02-08 | 2023-02-09 | 700,000 | — | $0 | 700,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2023-02-08 | 2023-02-09 | 500,000 | — | $0 | 5,971,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2023-01-31 | 2023-01-31 | 20,000 | $4.05 | $81.0K | 5,471,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2023-01-24 | 2023-01-24 | 20,000 | $4.19 | $83.8K | 5,451,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-09-28 | 2022-09-28 | 10,000 | $2.32 | $23.2K | 5,431,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-09-26 | 2022-09-27 | 15,000 | $2.27 | $34.0K | 5,421,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-09-07 | 2022-09-08 | 15,000 | $3.03 | $45.5K | 5,406,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-09-01 | 2022-09-01 | 15,000 | $2.83 | $42.5K | 5,391,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-08-17 | 2022-08-17 | 15,000 | $3.05 | $45.8K | 5,376,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-08-10 | 2022-08-10 | 15,000 | $2.64 | $39.6K | 5,361,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-08-01 | 2022-08-02 | 15,000 | $2.58 | $38.7K | 5,346,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-06-21 | 2022-06-21 | 20,000 | $2.80 | $56.0K | 5,331,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-06-16 | 2022-06-17 | 20,000 | $2.34 | $46.8K | 5,311,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-06-13 | 2022-06-13 | 30,000 | $2.29 | $68.7K | 5,291,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-06-06 | 2022-06-07 | 30,000 | $2.83 | $84.9K | 5,261,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-06-01 | 2022-06-01 | 20,000 | $3.03 | $60.6K | 5,231,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-26 | 2022-05-26 | 20,000 | $3.04 | $60.8K | 5,211,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-23 | 2022-05-24 | 18,355 | $2.72 | $49.9K | 5,191,873 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-17 | 2022-05-17 | 20,215 | $2.47 | $49.9K | 5,173,518 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-10 | 2022-05-10 | 27,836 | $1.80 | $50.1K | 5,153,303 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 700,000 | — | $0 | 700,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-17 | 2022-02-18 | 700,000 | — | $0 | 700,000 | SEC↗ |
| NONE Compass Therapeutics, Inc. | A Award | 2021-11-16 | 2021-11-18 | 600,000 | — | $0 | 5,125,467 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2021-02-09 | 2021-03-01 | 700,000 | — | $0 | 700,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2020-12-22 | 2020-12-23 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NONE Compass Therapeutics, Inc. | A Award deriv | 2020-08-06 | 2020-08-10 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NONE Compass Therapeutics, Inc. | P Buy | 2020-06-19 | 2020-06-23 | 97,431 | $5.00 | $487.2K | 4,525,467 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,086 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 5,605 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 89,695 | $60.00 | $5.38M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 16,200 | — | $0 | 16,200 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-06-08 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-10-08 | 2017-10-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 1,744 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 3,828 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 6,976 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 581 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 10,140 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 9,011 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 15,697 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 872 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 33,962 | $32.00 | $1.09M | 2,250 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 2,250 | $32.00 | $72.0K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2016-08-24 | 2016-08-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-21 | 2016-06-23 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-21 | 2016-06-23 | 2,250 | — | $0 | 36,212 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2016-03-15 | 2016-03-16 | 30,000 | $13.39 | $401.7K | 33,962 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-06-11 | 2015-06-15 | 1,000 | $34.57 | $34.6K | 3,962 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-06-04 | 2015-06-08 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-06-04 | 2015-06-08 | 2,250 | — | $0 | 4,962 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-06-19 | 2014-06-23 | 3,828 | — | $0 | 3,828 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-06-19 | 2014-06-23 | 2,712 | — | $0 | 2,712 | SEC↗ |